Search

You searched for "Referrals"

1515 results found

Doctor at large

1 October 2021 | | EYE - Vitreo-Retinal, EYE - General
“In 1930, the Republican-controlled House of Representatives, in an effort to alleviate the effects of the… Anyone? Anyone?... the Great Depression, passed the… Anyone? Anyone? The tariff bill? The Hawley-Smoot Tariff Act? Which, anyone…?” In this memorable scene, the monotonous...

Doctor by the sea (Pete’s Hidden Curriculum Part 1)

1 February 2022 | | EYE - General
See Pete's Hidden Curriculum Part 2 here. “They can always hurt you more.” This is The Fat Man’s Law Number 8 from the book The House of God by Samuel Shem. For those that have not read this book, it...

What’s Eating Gilbert Pete

2 August 2022 | | EYE - General
“Please phone Mr C Lyon ASAP on 0131 334 9171” This was a message from my secretary waiting for me on my computer one morning shortly after I was appointed a consultant. The name did not ring any bells but...

It’s Friday, I’m In Love: Pete’s Hidden Curriculum Part 3

3 February 2023 | | EYE - General
“When you’re in love, it’s the most glorious two-and-a-half days of your life.” - Richard Lewis [1]. The good news is that we are over the hump now and past the most depressing day of the year, which is known...

A window to 2024 and beyond?

3 April 2024 | | EYE - Cornea
The connection between the eye and systemic diseases has been acknowledged for millenia. Historical records suggest that ancient civilisations had some understanding of the eye’s significance beyond its primary function in vision. For instance, in ancient Egypt, the ‘Eye of...

Artificial intelligence and oculomics: Improving global health

2 June 2025 | | EYE - Imaging
The application of artificial intelligence (AI), and in particular deep learning, to high-resolution ocular imaging has led to many new discoveries, enabling the prediction of multiple different systemic diseases from ocular biomarkers. This emerging field is known as ‘oculomics’ [1]....

My Top Five: Ophthalmology podcasts for trainees

7 December 2020 | | EYE - Vitreo-Retinal, EYE - General
Our schedules are seriously crowded these days, whether it be running from clinic to clinic, squeezing in lunch meetings, or trying to run errands after work, by the time we arrive at home we are too mentally exhausted to do...

The symbolism of eyes in Halloween traditions and popular culture

31 October 2025 | | EYE - General
Halloween is a festival steeped in symbolism. Pumpkins, skeletons, ghosts and witches dominate the seasonal iconography, each representing broader cultural anxieties about death, darkness and the supernatural. Among these motifs, the eye, often depicted as glowing, disembodied or grotesquely exaggerated,...

Coaching: Supporting doctors’ development and wellbeing

20 October 2025 | | EYE - General
Supporting and retaining the workforce is a top priority for all NHS organisations, but it’s not clear how best to do this, or how such support should be funded. Junior doctors have clinical and educational supervision, and the quality of...

What's trending Oct/Nov 2025

2 October 2025 | | EYE - General
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #AlienEarth #TheEye One of the best shows to recently start streaming is, in my opinion, Alien: Earth. The cosmic horror of...

Semaglutide and vision loss: A new concern for NAION risk?

4 December 2025 | | EYE - Neuro-ophthalmology
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as transformative agents in...

My Top Five: Promising gene therapies for ocular conditions

4 December 2024 | | EYE - Vitreo-Retinal
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...